BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8012072)

  • 1. Pheochromocytoma associated with nocturnal hypertension.
    Ishiyama Y; Ohgi T; Kita T; Sasaki A; Kitamura K; Kida O; Kawasaki T; Eto T
    Intern Med; 1993 Oct; 32(10):781-3. PubMed ID: 8012072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration of neuropeptide Y in patients with adrenal hypertension.
    Tabarin A; Minot AP; Dallochio M; Roger P; Ducassou D
    Regul Pept; 1992 Nov; 42(1-2):51-61. PubMed ID: 1475406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas.
    Eurin J; Barthélemy C; Masson F; Maistre G; Soualmia H; Noé E; Sarfati E; Eurin B; Carayon A
    Regul Pept; 2000 Jan; 86(1-3):95-102. PubMed ID: 10672908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
    Eisenhut S; Rascher W; Lang RE
    Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phaeochromocytoma with nocturnal elevation of blood pressure.
    Yamamoto T; Jo T; Ishibashi T
    Postgrad Med J; 1978 Jan; 54(627):40-2. PubMed ID: 625458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression.
    Louis WJ; Doyle AE; Anavekar SN
    Clin Sci Mol Med Suppl; 1975 Jun; 2():239s-242s. PubMed ID: 802639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
    Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines.
    Fouad-Tarazi FM; Imamura M; Bravo EL; Rossi G; Nagi HK; Lin WW; Cressman M; Wicker P
    Am J Hypertens; 1992 Mar; 5(3):134-40. PubMed ID: 1533527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet norepinephrine and epinephrine concentration in patients with pheochromocytoma.
    Berent H; Uchman B; Wocial B; Januszewicz W
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):618-21. PubMed ID: 2222953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snuff-induced hypertension in pheochromocytoma.
    McPhaul M; Punzi HA; Sandy A; Borganelli M; Rude R; Kaplan NM
    JAMA; 1984 Nov 23-30; 252(20):2860-2. PubMed ID: 6541713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus and pheochromocytoma.
    Wu JJ; Luo SF; Ho HH
    J Rheumatol; 1992 Jun; 19(6):982-4. PubMed ID: 1404141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension.
    Constantinescu G; Langton K; Conrad C; Amar L; Assié G; Gimenez-Roqueplo AP; Blanchard A; Larsen CK; Mulatero P; Williams TA; Prejbisz A; Fassnacht M; Bornstein S; Ceccato F; Fliedner S; Dennedy M; Peitzsch M; Sinnott R; Januszewicz A; Beuschlein F; Reincke M; Zennaro MC; Eisenhofer G; Deinum J
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3374-83. PubMed ID: 32609829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial preservation of nocturnal fall in blood pressure in patients with catecholamine-producing tumours.
    Statius van Eps RG; van den Meiracker AH; Boomsma F; Man in 't Veld AJ; Schalekamp MA
    J Hypertens Suppl; 1993 Dec; 11(5):S168-9. PubMed ID: 8158326
    [No Abstract]   [Full Text] [Related]  

  • 15. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
    Pruszczyk P; Wocial B; Ignatowska-Switalska H; Feltynowski T; Ellafi M; Januszewicz A; Lapiński M; Zukowska-Grojec Z; Januszewicz W
    Clin Chim Acta; 1995 Dec; 243(2):205-12. PubMed ID: 8747495
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients.
    Zelinka T; Strauch B; Petrák O; Holaj R; Vranková A; Weisserová H; Pacák K; Widimský J
    J Hypertens; 2005 Nov; 23(11):2033-9. PubMed ID: 16208146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. Its relation to hypertension.
    Puyo A; Levin G; Armando I; Barontini M
    Hypertension; 1988 Feb; 11(2 Pt 2):I202-6. PubMed ID: 3346058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in patients with pheochromocytoma.
    Hanna NN; Kenady DE
    Curr Hypertens Rep; 1999 Dec; 1(6):540-5. PubMed ID: 10981118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations in New England Deaconess Hospital rats harboring pheochromocytoma.
    Hoffman BB
    Clin Invest Med; 1987 Nov; 10(6):555-60. PubMed ID: 2831003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and conjugated plasma catecholamines in pheochromocytoma patients with and without sustained hypertension.
    Puyó AM; Levin GM; Armando I; Barontini MB
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):111-7. PubMed ID: 3766042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.